Negative citations; cardiac stem cell saga continues; identifying anonymized genomic study participants; evolution of allergens; a call for biodefense innovation
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.